Chang, Ching-Yuan
Jones, Bobby L.
Hincapie-Castillo, Juan M.
Park, Haesuk
Heldermon, Coy D.
Diaby, Vakaramoko
Wilson, Debbie L. http://orcid.org/0000-0002-1640-5497
Lo-Ciganic, Wei-Hsuan http://orcid.org/0000-0001-6590-4770
Article History
Received: 4 November 2023
Revised: 26 March 2024
Accepted: 3 April 2024
First Online: 18 April 2024
Competing interests
: W.-H.L.-C. reported receiving grants from the National Institute on Drug Abuse, the National Institute on Aging, the National Institute of Mental Health, Merck Sharp & Dohme, Bristol Myers Squibb, the Richard King Mellon Foundation at the University of Pittsburgh, the Clinical and Translational Science Institute of the University of Florida, the Pharmaceutical Research and Manufacturers of America Foundation, and the US Department of Veterans Affairs outside the submitted work; and having a patent pending for U1195.70174US00. H.P. reported receiving grants from Bristol Myers Squibb/Pfizer Alliance American Thrombosis Investigator Initiated Research Program outside the submitted work. J.M.H.-C. reported receiving grants from Merck & Co outside the submitted work. D.L.W. reported receiving grants from the National Institute on Drug Abuse, the National Institute on Aging, Merck Sharp & Dohme, and Bristol Myers Squibb outside the submitted work; and serving as an editorial board member for the <i>Journal of Pharmacy Technology</i>. C.-Y.C. contributions to this manuscript were made while at the University of Florida College of Pharmacy. C.-Y.C. is currently employed by Vertex Pharmaceuticals, Inc. Vertex did not fund or have any involvement in this study or publication. V.D. is currently employed by Otsuka, Inc. Otsuka did not fund or have any involvement in this study or publication. No other disclosures were reported.
: This study was approved by the institutional review board at the University of Florida, which waived the need for obtaining informed consent.